195 related articles for article (PubMed ID: 37999120)
1. Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective.
Husereau D; Bombard Y; Stockley T; Carter M; Davey S; Lemaire D; Nohr E; Park P; Spatz A; Williams C; Pollett A; Lo B; Yip S; El Hallani S; Feilotter H
Curr Oncol; 2023 Oct; 30(11):9660-9669. PubMed ID: 37999120
[TBL] [Abstract][Full Text] [Related]
2. Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs.
Liu G; Cheung WY; Feilotter H; Manthorne J; Stockley T; Yeung M; Renouf DJ
Curr Oncol; 2022 Sep; 29(10):7257-7271. PubMed ID: 36290849
[TBL] [Abstract][Full Text] [Related]
3. Genomic medicine in neonatal care: progress and challenges.
D'Gama AM; Agrawal PB
Eur J Hum Genet; 2023 Dec; 31(12):1357-1363. PubMed ID: 37789085
[TBL] [Abstract][Full Text] [Related]
4. Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling.
Tarride JE; Gould T; Thomas DM
Int J Technol Assess Health Care; 2022 Jun; 38(1):e57. PubMed ID: 35674123
[TBL] [Abstract][Full Text] [Related]
5. Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop.
Hughes KS; Ambinder EP; Hess GP; Yu PP; Bernstam EV; Routbort MJ; Clemenceau JR; Hamm JT; Febbo PG; Domchek SM; Chen JL; Warner JL;
J Clin Oncol; 2017 Sep; 35(27):3153-3159. PubMed ID: 28737972
[TBL] [Abstract][Full Text] [Related]
6. Equity in Genomic Medicine.
Halbert CH
Annu Rev Genomics Hum Genet; 2022 Aug; 23():613-625. PubMed ID: 35363547
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systems.
Husereau D; Sullivan T; Feilotter HE; Gomes MM; Juergens R; Sheffield BS; Kassam S; Stockley TL; Jacobs P
J Med Econ; 2022; 25(1):993-1004. PubMed ID: 35850613
[TBL] [Abstract][Full Text] [Related]
8. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
McGowan ML; Settersten RA; Juengst ET; Fishman JR
Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
[TBL] [Abstract][Full Text] [Related]
9. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD; Ford JM; Pritchard D; Brown T
Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
[TBL] [Abstract][Full Text] [Related]
10. Managing the introduction of genomic applications into the National Health Service: A special challenge for health technology assessment in Italy.
Pitini E; Migliara G; Baccolini V; Isonne C; Mazzalai E; Turatto F; Salerno C; Pagano F; Menzano MT; De Vito C; Marzuillo C; Villari P
Front Public Health; 2022; 10():932093. PubMed ID: 36033790
[TBL] [Abstract][Full Text] [Related]
11. Translating genomics in cancer care.
Bombard Y; Bach PB; Offit K
J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
[TBL] [Abstract][Full Text] [Related]
12. The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group.
Chan KKW; Cheung MC; Regier DA; Hay A; Louie AV; Cheung WY; Tarride JE; Udayakumar S; Mittmann N
Curr Oncol; 2021 Sep; 28(5):3649-3658. PubMed ID: 34590616
[TBL] [Abstract][Full Text] [Related]
13. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
14. Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic.
Raheem F; Kim P; Grove M; Kiel PJ
Pharmacy (Basel); 2020 Mar; 8(1):. PubMed ID: 32182657
[TBL] [Abstract][Full Text] [Related]
15. Challenges and opportunities in building a health economic framework for personalized medicine in oncology.
Aguiar PN; Matsas S; Dienstmann R; Ferreira CG
Per Med; 2023 Sep; 20(5):453-460. PubMed ID: 37602420
[TBL] [Abstract][Full Text] [Related]
16. Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review.
Rahman B; McEwen A; Phillips JL; Tucker K; Goldstein D; Jacobs C
Per Med; 2022 Mar; 19(2):139-153. PubMed ID: 35060769
[TBL] [Abstract][Full Text] [Related]
17. Delivering precision oncology to patients with cancer.
Mateo J; Steuten L; Aftimos P; André F; Davies M; Garralda E; Geissler J; Husereau D; Martinez-Lopez I; Normanno N; Reis-Filho JS; Stefani S; Thomas DM; Westphalen CB; Voest E
Nat Med; 2022 Apr; 28(4):658-665. PubMed ID: 35440717
[TBL] [Abstract][Full Text] [Related]
18. The Application of Genomics in Diabetes: Barriers to Discovery and Implementation.
Floyd JS; Psaty BM
Diabetes Care; 2016 Nov; 39(11):1858-1869. PubMed ID: 27926887
[TBL] [Abstract][Full Text] [Related]
19. Implementing precision cancer medicine in the genomic era.
Chen HZ; Bonneville R; Roychowdhury S
Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the potential of reverse-phase protein array technology: Advancing precision oncology strategies.
Masuda M; Nakagawa R; Kondo T
Cancer Sci; 2024 May; 115(5):1378-1387. PubMed ID: 38409909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
